CD Biosynsis provides specialized Chlamydomonas reinhardtii Multi-Gene Knockout Strain Construction services, enabling the simultaneous or sequential disruption of multiple genomic loci. In algal synthetic biology, many metabolic pathways and physiological functions are governed by redundant gene families or branched networks where a single knockout is insufficient to produce a significant phenotype. Our platform utilizes advanced multiplexed CRISPR-Cas9 and Cas12a technologies to bypass these redundancies, allowing for the creation of complex mutant libraries and "clean" chassis strains. By eliminating entire metabolic competitive pathways, we provide researchers with a streamlined algal system for high-value bioproduction and fundamental functional genomics.
Constructing multi-gene knockout strains in Chlamydomonas reinhardtii requires a sophisticated strategy to manage the cumulative stress on the cell and the selection of appropriate markers. Our approach leverages DNA-free Ribonucleoprotein (RNP) delivery, which reduces the metabolic burden and genomic instability associated with traditional plasmid-based methods. We offer various strategies, including the use of poly-cistronic gRNA arrays and "scarless" editing techniques that allow for the recycling of selection markers. This is particularly critical for large-scale engineering projects where four or more genes must be inactivated to redirect carbon flux from starch to lipid biosynthesis or to eliminate endogenous proteases for improved recombinant protein stability. Our service ensures that each modification is verified for both genotypic accuracy and phenotypic stability across generations.
Get a QuoteThe complexity of the Chlamydomonas genome, with its frequent gene duplications, often necessitates the disruption of multiple paralogs to observe a clear loss-of-function. Our multi-gene knockout service is designed to address this biological hurdle by providing precise, simultaneous targeting of up to four loci in a single transformation event. This efficiency is achieved through the optimization of gRNA spacers and the use of high-fidelity nucleases that maintain high activity in the 64 percent GC environment of the algal nucleus. [Image showing simultaneous CRISPR targeting of multiple genomic loci in a Chlamydomonas cell]
Beyond simple gene disruption, our platform facilitates the development of specialized "deletion strains" where large genomic fragments or entire gene clusters can be removed. This is highly effective for removing unwanted secondary metabolite pathways or cleaning the host background for the expression of synthetic genetic circuits. Each strain undergoes rigorous monoclonal isolation and deep sequencing to confirm the absence of unintended off-target mutations, providing you with a genetically defined and stable platform for your downstream photosynthetic research.
gRNA Arrays
Delivery of multiple gRNAs targeting different genes in a single RNP complex or a single expression cassette to disrupt entire gene families simultaneously.
Efficiency Optimization
Utilization of optimized CRISPR-Cas12a systems, which naturally process their own crRNA arrays, simplifying the construction of multi-target vectors.
Marker Recycling
Application of Cre-Lox or similar recombinase systems to remove selection markers after each knockout round, allowing for an unlimited number of genetic modifications.
Iterative Selection
Successive rounds of transformation and monoclonal isolation to build complex phenotypes while monitoring cell fitness at each stage.
Dual-gRNA Targeting
Using two gRNAs flanking a target region to induce large-scale chromosomal deletions, ideal for removing metabolic clusters or redundant repeats.
Clean Chassis Design
Removal of multiple endogenous proteases or non-essential genes to create a streamlined algal host with reduced metabolic background and improved recombinant stability.
1. Bioinformatic Mapping
2. Multiplex Tool Synthesis
3. Transformation & Dual Screening
4. Multi-Locus Verification
Identification of paralogs and redundant pathway genes. Strategic selection of gRNA targets across multiple loci to ensure maximum disruption efficiency and minimum off-target risk in the GC-rich genome.
Synthesis of gRNA arrays or high-concentration RNP pools. Optimization of Cas9/Cas12a nuclease concentration for multiplexed delivery. [Image showing the preparation of CRISPR-Cas complexes for multiple gene targeting]
Genotyping: Confirmation of all targeted disruptions via Sanger sequencing or Next-Generation Sequencing (NGS). Phenotypic Analysis: Verification of the cumulative metabolic or physiological effect. Delivery of cryopreserved poly-mutant strains.
Pathway-Wide Control
Enables the complete inactivation of entire metabolic branches, which is essential for redirecting flux toward biofuels or specialty pigments.
High Efficiency RNPs
Using DNA-free RNPs ensures high transient activity for multiple cuts while preventing the integration of Cas DNA, leading to cleaner mutant backgrounds.
Redundancy Bypass
Specifically designed to overcome the genetic robustness of Chlamydomonas by targeting multiple gene family members in a single step.
Stable Poly-Mutants
Rigorous monoclonal isolation and stability trials over 50 passages ensure that complex multi-gene phenotypes are genetically fixed and stable.
1. How many genes can be knocked out simultaneously?
Using our optimized RNP and gRNA array platforms, we can typically disrupt 2-4 genes in a single transformation. For more complex engineering, we recommend a sequential "stacking" approach.
2. What is the success rate for obtaining a triple or quadruple knockout?
While efficiency decreases with each additional target, our high-throughput automated screening allows us to isolate rare poly-mutant clones with high reliability.
3. Can you perform multi-gene knockouts in the chloroplast?
Yes. However, due to the polyploid nature of the chloroplast, achieving homoplasmy across multiple loci requires specialized selection and several rounds of plating.
4. How do you manage the lack of multiple antibiotic markers?
We utilize DNA-free RNP delivery which does not necessarily require permanent markers, or we employ marker-recycling systems (e.g., Cre-Lox) for sequential projects.
5. Is the growth of the multi-knockout strain affected?
Depending on the genes targeted, some fitness cost may occur. We provide growth kinetic data for all delivered strains to quantify any impact on biomass productivity.
6. Do you use NGS to verify the multi-gene mutants?
Yes, for multi-gene projects, targeted NGS is the gold standard we use to confirm the genotype at every target locus and to check for unintended deletions between loci.
7. Can you delete large gene clusters instead of individual genes?
Absolutely. We can design gRNAs to flank a large genomic region (up to several dozen kilobases) to induce a fragment deletion, which is often cleaner than multiple individual indels.
8. What is the typical turnaround time for a triple knockout strain?
A simultaneous triple knockout project usually takes 16 to 20 weeks, including design, multiple screening rounds, and deep genomic verification.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.